Knight Therapeutics | GUD - Deudores Comerciales

Precio De Mercado
8.66
Cambio Diario
-0.03 -0.35%
Mensual
13.65%
Anual
47.78%
Q2 Expectativa
8.51




Deudores Comerciales Cambio Fecha
Acasti Pharma USD 20K 0 2025-09
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Avita Medical AUD 9.11M 2.26M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Cronos Group USD 73.17M 4.87M 2026-03
Dianthus Therapeutics USD 52K 4.95M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Moderna USD 71M 113M 2026-03
Omeros USD 8.08M 440K 2024-06
Organigram Holdings CAD 49.94M 14.92M 2025-12
Organon & Co USD 1.33B 153M 2025-12
Revvity USD 691.38M 53.29M 2026-03
Tectonic Therapeutic USD 0 270K 2023-12
Tilray USD 109.07M 2M 2025-09
Viatris USD 3.08B 45M 2026-03
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12